E-LIB Suche - Ergebnisse für: Kang, Yoonkoo

1

Ripretinib versus sunitinib in gastrointestinal stromal tum..:

Heinrich, Michael C. ; Jones, Robin L. ; George, Suzanne...
Nature Medicine. 30 (2024) 2 - p. 498-506 , 2024

2

Adjuvant nivolumab plus chemotherapy versus placebo plus ch..:

Kang, Yoon-Koo ; Terashima, Masanori ; Kim, Young-Woo...
The Lancet Gastroenterology & Hepatology. 9 (2024) 8 - p. 705-717 , 2024

Link: https://doi.org/10.1016/..

3

GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 ..:

Hyung, Jaewon ; Kim, Hyung-Don ; Ryu, Min-Hee...
Cancer Research and Treatment. 56 (2024) 1 - p. 199-207 , 2024

Link: https://doi.org/10.4143/..

4

Adjuvant treatment for locally advanced gastric cancer: an ..:

Kim, Hyung-Don ; Ryu, Min-Hee ; Kang, Yoon-Koo
Gastric Cancer. 27 (2024) 3 - p. 439-450 , 2024

Link: https://doi.org/10.1007/..

5

Bemarituzumab as first-line treatment for locally advanced ..:

Wainberg, Zev A. ; Kang, Yoon-Koo ; Lee, Keun-Wook...
Gastric Cancer. 27 (2024) 3 - p. 558-570 , 2024

Link: https://doi.org/10.1007/..

6

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiog..:

Kang, Yoon-Koo ; Ryu, Min-Hee ; Hong, Yong Sang...
Cancer Research and Treatment. 56 (2024) 3 - p. 743-750 , 2024

Link: https://doi.org/10.4143/..

7

Letter to the editor: 5-year follow-up results of a JCOG110..:

Kim, Hyung-Don ; Ryu, Min-Hee ; Lee, Ji Sung.
Gastric Cancer. 27 (2024) 4 - p. 884-885 , 2024

Link: https://doi.org/10.1007/..

8

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously..:

Kang, Yoon-Koo ; Ryu, Min-Hee ; Di Bartolomeo, Maria...
Gastric Cancer. 27 (2024) 2 - p. 375-386 , 2024

Link: https://doi.org/10.1007/..

9

Bemarituzumab plus mFOLFOX6 as first-line treatment in East..:

Kang, Yoon-Koo ; Qin, Shukui ; Lee, Keun-Wook...
Gastric Cancer. , 2024

Link: https://doi.org/10.1007/..

10

Prognostic value of mismatch repair deficiency in patients ..:

Oh, Chung Ryul ; Kim, Eo Jin ; Chae, Heejung...
Gastric Cancer. 27 (2024) 4 - p. 811-818 , 2024

Link: https://doi.org/10.1007/..

11

PP213 Three-year follow-up of the ATTRACTION-4 Korean subgr..:

Ryu, Min-Hee ; Kang, Yoon-Koo ; Oh, Do-Youn...
ESMO Open. 8 (2023) 1 - p. 102169 , 2023

Link: https://doi.org/10.1016/..

12

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

A randomised phase 2 study of continuous or intermittent do..:

Kim, Hyung-Don ; Yoo, Changhoon ; Ryu, Min-Hee.
British Journal of Cancer. 129 (2023) 2 - p. 275-282 , 2023

Link: https://doi.org/10.1038/..

14

Clinical outcomes of Epstein–Barr virus (EBV)-associated me..:

Kim, Eo Jin ; Chae, Heejung ; Park, Young-Soo...
Gastric Cancer. , 2023

Link: https://doi.org/10.1007/..

15

DNA mismatch repair deficiency and outcomes of patients wit..:

Hyung, Jaewon ; Cho, Hyungwoo ; Kim, Hyung-Don...
Gastric Cancer. , 2023

Link: https://doi.org/10.1007/..